Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Mar 1;153(3):534-44.
doi: 10.1084/jem.153.3.534.

Special features of the priming process for a secretory IgA response. B cell priming with cholera toxin

Special features of the priming process for a secretory IgA response. B cell priming with cholera toxin

J A Fuhrman et al. J Exp Med. .

Abstract

Administration of cholera toxin/toxoid by either intraduodenal or parenteral routes increases the frequency of antigen-sensitive B cells in Peyer's patches (PP) and in distant lymphoid tissues greater than 50-fold. The special feature of mucosal priming with toxin is its unique effectiveness at generating secondary B cells, whose progeny express IgA exclusively, and such cells appear in highest frequency in PP and in appreciable numbers in spleen. Thus, this deliberate intraduodenal immunization seems to mimic the natural priming process induced by enteric bacterial colonization, which we have postulated to account for the high frequencies of IgA-committed cells specific for bacterial determinants in the PP of conventionally reared mice. furthermore, as a result of intraduodenal immunization, antigen-specific memory B cells are disseminated to sites distant form that of antigen application, including the lymphoid follicles associated with the respiratory mucosa. Direct antigenic stimulation of cells in the PP therefore results in effective cross-priming among mucosal and systemic sites through division, differentiation, and disemination of antigen-sensitive secondary B cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1966 Nov 24;275(21):1145-52 - PubMed
    1. Clin Exp Immunol. 1969 Apr;4(4):473-87 - PubMed
    1. J Exp Med. 1969 Oct 1;130(4):723-44 - PubMed
    1. Immunochemistry. 1969 Sep;6(5):757-9 - PubMed
    1. J Infect Dis. 1972 Jun;125(6):647-55 - PubMed

Publication types